# Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

> **NCT07235748** · PHASE1 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier (I.R.I.S.)** · enrollment: 28 (actual)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** Vorasidenib
- **DRUG:** Bupropion
- **DRUG:** Flurbiprofen
- **DRUG:** Omeprazole
- **DRUG:** Midazolam
- **DRUG:** Repaglinide
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT07235748
- **Lead sponsor:** Institut de Recherches Internationales Servier (I.R.I.S.)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-07
- **Primary completion:** 2025-12-23
- **Final completion:** 2025-12-23
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07235748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07235748, "Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07235748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*